International League Against Epilepsy classification and definition of epilepsy syndromes with onset at a variable age: position statement by the ILAE Task Force on Nosology and Definitions.
Rasmussen syndrome
epilepsy with reading-induced seizures
focal epilepsy syndromes
mesial temporal lobe epilepsy with hippocampal sclerosis
progressive myoclonus epilepsies
Journal
Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
revised:
12
03
2022
received:
23
04
2021
accepted:
16
03
2022
pubmed:
4
5
2022
medline:
7
6
2022
entrez:
3
5
2022
Statut:
ppublish
Résumé
The goal of this paper is to provide updated diagnostic criteria for the epilepsy syndromes that have a variable age of onset, based on expert consensus of the International League Against Epilepsy Nosology and Definitions Taskforce (2017-2021). We use language consistent with current accepted epilepsy and seizure classifications and incorporate knowledge from advances in genetics, electroencephalography, and imaging. Our aim in delineating the epilepsy syndromes that present at a variable age is to aid diagnosis and to guide investigations for etiology and treatments for these patients.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1443-1474Informations de copyright
© 2022 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.
Références
Wirrell EC, Nabbout R, Scheffer IE, Alsaadi T, Bogacz A, French J, et al. Methodology for classification and definition of epilepsy syndromes with list of syndromes: report of the ILAE Task Force on Nosology and Definitions. Epilepsia. In press.
Zuberi SM, Wirrell E, Yozawitz E, Wilmshurst J, Specchio N, Riney K, et al. ILAE classification and definition of epilepsy syndromes in the neonate and infant: position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia. In press.
Specchio N, Wirrell EC, Scheffer IE, Nabbout R, Riney K, Samia P, et al. ILAE classification and definition of epilepsy syndromes with onset in childhood: position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia. In press.
Hirsch E, French J, Scheffer IE, Bogacz A, Alsaadi T, Sperling M, et al. ILAE definition of idiopathic generalized epilepsy syndromes: position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia. In press.
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-24. https://doi.org/https://doi.org/10.1038/gim.2015.30
Jallon P, Latour P. Epidemiology of idiopathic generalized epilepsies. Epilepsia. 2005;46(Suppl 9):10-4.
Gastaut H, Zifkin BG. Benign epilepsy of childhood with occipital spike and wave complexes. In: Andermann F, Lugaresi E, editors. Migraine and epilepsy. Boston, MA: Butterworths; 1987. p. 47-81.
Gastaut H, Roger J, Bureau M. Benign epilepsy of childhood with occipital paroxysms. In: Roger J, Bureau M, Dravet C, Dreifuss F, Perret A, Wolf P, editors. Epileptic syndromes in infancy, childhood and adolescence. 2nd ed. London, UK: John Libbey & Company; 1992. p. 201-17.
Caraballo RH, Cersósimo RO, Fejerman N. Childhood occipital epilepsy of Gastaut: a study of 33 patients. Epilepsia. 2008;49(2):288-97.
Koutroumanidis M, Tsirka V, Panayiotopoulos C. Adult-onset photosensitivity: clinical significance and epilepsy syndromes including idiopathic (possibly genetic) photosensitive occipital epilepsy. Epileptic Disord. 2015;17(3):275-86.
Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010;51:676-85.
Scheffer IE, Phillips HA, O'Brien CE, Saling MM, Wrennall JA, Wallace RH, et al. Familial partial epilepsy with variable foci: a new partial epilepsy syndrome with suggestion of linkage to chromosome 2. Ann Neurol. 1998;44:890-9.
Provini F, Plazzi G, Tinuper P, Vandi S, Lugaresi E, Montagna P. Nocturnal frontal lobe epilepsy. A clinical and polygraphic overview of 100 consecutive cases. Brain. 1999;122(Pt 6):1017-31.
Berkovic SF, Serratosa JM, Phillips HA, Xiong L, Andermann E, Diaz-Otero F, et al. Familial partial epilepsy with variable foci: clinical features and linkage to chromosome 22q12. Epilepsia. 2004;45:1054-60.
Licchetta L, Pippucci T, Baldassari S, Minardi R, Provini F, Mostacci B, et al. Sleep-related hypermotor epilepsy (SHE): contribution of known genes in 103 patients. Seizure. 2020;74:60-4.
Scheffer IE, Heron SE, Regan BM, Mandelstam S, Crompton DE, Hodgson BL, et al. Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations. Ann Neurol. 2014;75:782-7.
Picard F, Makrythanasis P, Navarro V, Ishida S, de Bellescize J, Ville D, et al. DEPDC5 mutations in families presenting as autosomal dominant nocturnal frontal lobe epilepsy. Neurology. 2014;10(82):2101-6.
Ricos MG, Hodgson BL, Pippucci T, Saidin A, Ong YS, Heron SE, et al. Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsy. Ann Neurol. 2016;79:120-31.
Korenke GC, Eggert M, Thiele H, Nürnberg P, Sander T, Steinlein OK. Nocturnal frontal lobe epilepsy caused by a mutation in the GATOR1 complex gene NPRL3. Epilepsia. 2016;57:e60-3.
Tinuper P, Bisulli F, Cross JH, Hesdorffer D, Kahane P, Nobili L, et al. Definition and diagnostic criteria of sleep-related hypermotor epilepsy. Neurology. 2016;10(86):1834-42.
Licchetta L, Bisulli F, Vignatelli L, Zenesini C, Di Vito L, Mostacci B, et al. Sleep-related hypermotor epilepsy: long-term outcome in a large cohort. Neurology. 2017;3(88):70-7.
Vignatelli L, Bisulli F, Giovannini G, Licchetta L, Naldi I, Mostacci B, et al. Prevalence of sleep-related hypermotor epilepsy-formerly named nocturnal frontal lobe epilepsy-in the adult population of the Emilia-Romagna region, Italy. Sleep. 2017;1:40.
Licchetta L, Poda R, Vignatelli L, Pippucci T, Zenesini C, Menghi V, et al. Profile of neuropsychological impairment in sleep-related hypermotor epilepsy. Sleep Med. 2018;48:8-15.
Gibbs SA, Proserpio P, Francione S, Mai R, Cardinale F, Sartori I, et al. Clinical features of sleep-related hypermotor epilepsy in relation to the seizure-onset zone: a review of 135 surgically treated cases. Epilepsia. 2019;60:707-17.
Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE, et al. Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58:522-30.
Scheffer IE, Bhatia KP, Lopes-Cendes I, Fish DR, Marsden CD, Andermann E, et al. Autosomal dominant nocturnal frontal lobe epilepsy. A distinctive clinical disorder. Brain. 1995;118(Pt 1):61-73.
Oldani A, Zucconi M, Asselta R, Modugno M, Bonati MT, Dalprà L, et al. Autosomal dominant nocturnal frontal lobe epilepsy. A video-polysomnographic and genetic appraisal of 40 patients and delineation of the epileptic syndrome. Brain. 1998;121(Pt 2):205-23.
Heron SE, Smith KR, Bahlo M, Nobili L, Kahana E, Licchetta L, et al. Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet. 2012;44:1188-90.
Derry CP, Heron SE, Phillips F, Howell S, MacMahon J, Phillips HA, et al. Severe autosomal dominant nocturnal frontal lobe epilepsy associated with psychiatric disorders and intellectual disability. Epilepsia. 2008;49:2125-9.
Perucca P. Genetics of focal epilepsies: what do we know and where are we heading? Epilepsy Curr. 2018;18:356-62.
Losurdo A, Proserpio P, Cardinale F, Gozzo F, Tassi L, Mai R, et al. Drug-resistant focal sleep related epilepsy: results and predictors of surgical outcome. Epilepsy Res. 2014;108(5):953-62.
Ryvlin P, Minotti L, Demarquay G, Hirsch E, Arzimanoglou A, Hoffman D, et al. Nocturnal hypermotor seizures, suggesting frontal lobe epilepsy, can originate in the insula. Epilepsia. 2006;47:755-65.
Nobili L, Francione S, Mai R, Cardinale F, Castana L, Tassi L, et al. Surgical treatment of drug-resistant nocturnal frontal lobe epilepsy. Brain. 2007;130:561-73.
Proserpio P, Cossu M, Francione S, Tassi L, Mai R, Didato G, et al. Insular-opercular seizures manifesting with sleep-related paroxysmal motor behaviors: a stereo-EEG study. Epilepsia. 2011;52:1781-91.
Steinlein OK, Mulley JC, Propping P, Wallace RH, Phillips HA, Sutherland GR, et al. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet. 1995;11:201-3.
De Fusco M, Becchetti A, Patrignani A, Annesi G, Gambardella A, Quattrone A, et al. The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet. 2000;26:275-6.
Aridon P, Marini C, Di Resta C, Brilli E, De Fusco M, Politi F, et al. Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear. Am J Hum Genet. 2006;79:342-50.
Hildebrand MS, Tankard R, Gazina EV, Damiano JA, Lawrence KM, Dahl HH, et al. PRIMA1 mutation: a new cause of nocturnal frontal lobe epilepsy. Ann Clin Transl Neurol. 2015;2:821-30.
Scheffer IE, Bhatia KP, Lopes-Cendes I, Fish DR, Marsden CD, Andermann F, et al. Autosomal dominant frontal epilepsy misdiagnosed as sleep disorder. Lancet. 1994;26(343):515-7.
Crompton DE, Scheffer IE, Taylor I, Cook MJ, McKelvie PA, Vears DF, et al. Familial mesial temporal lobe epilepsy: a benign epilepsy syndrome showing complex inheritance. Brain. 2010;133:3221-31.
Kobayashi E, Lopes-Cendes I, Guerreiro CA, Sousa SC, Guerreiro MM, Cendes F. Seizure outcome and hippocampal atrophy in familial mesial temporal lobe epilepsy. Neurology. 2001;23(56):166-72.
Cendes F, Lopes-Cendes I, Andermann E, Andermann F. Familial temporal lobe epilepsy: a clinically heterogeneous syndrome. Neurology. 1998;50:554-7.
Perucca P, Crompton DE, Bellows ST, McIntosh AM, Kalincik T, Newton MR, et al. Familial mesial temporal lobe epilepsy and the borderland of déjà vu. Ann Neurol. 2017;82:166-76.
Berkovic SF, McIntosh A, Howell RA, Mitchell A, Sheffield LJ, Hopper JL. Familial temporal lobe epilepsy: a common disorder identified in twins. Ann Neurol. 1996;40:227-35.
Cvetkovska E, Kuzmanovski I, Babunovska M, Boshkovski B, Cangovska TC, Trencevska GK. Phenotypic spectrum in families with mesial temporal lobe epilepsy probands. Seizure. 2018;58:13-6.
Morita ME, Yasuda CL, Betting LE, Pacagnella D, Conz L, Barbosa PH, et al. MRI and EEG as long-term seizure outcome predictors in familial mesial temporal lobe epilepsy. Neurology. 2012;79:2349.
Kobayashi E, D'Agostino MD, Lopes-Cendes I, Andermann E, Dubeau F, Guerreiro CAM, et al. Outcome of surgical treatment in familial mesial temporal lobe epilepsy. Epilepsia. 2003;44:1080-4.
Striano P, Serioli E, Santulli L, Manna I, Labate A, Dazzo E, et al. DEPDC5 mutations are not a frequent cause of familial temporal lobe epilepsy. Epilepsia. 2015;56:e168-71.
Callenbach PMC, Van Den Maagdenberg AMJM, Hottenga JJ, Van Den Boogerd EH, De Coo RFM, Lindhout D, et al. Familial partial epilepsy with variable foci in a Dutch family: clinical characteristics and confirmation of linkage to chromosome 22q. Epilepsia. 2003;44:1298-305.
Klein KM, O’Brien TJ, Praveen K, Heron SE, Mulley JC, Foote S, et al. Familial focal epilepsy with variable foci mapped to chromosome 22q12: expansion of the phenotypic spectrum. Epilepsia. 2012;53:e151-5.
Picard F, Baulac S, Kahane P, Hirsch E, Sebastianelli R, Thomas P, et al. Dominant partial epilepsies. a clinical, electrophysiological and genetic study of 19 European families. Brain. 2000;123(Pt 6):1247-62.
Baulac S, Ishida S, Marsan E, Miquel C, Biraben A, Nguyen DK, et al. Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations. Ann Neurol. 2015;77:675-83.
Dibbens LM, de Vries B, Donatello S, Heron SE, Hodgson BL, Chintawar S, et al. Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat Genet. 2013;45:546-51.
Bisulli F, Menghi V, Vignatelli L, Licchetta L, Zenesini C, Stipa C, et al. Epilepsy with auditory features: long-term outcome and predictors of terminal remission. Epilepsia. 2018;59:834-43.
Kobayashi E, Santos NF, Torres FR, Secolin R, Sardinha LAC, Lopez-Cendes I, et al. Magnetic resonance imaging abnormalities in familial temporal lobe epilepsy with auditory auras. Arch Neurol. 2003;60:1546-51.
Winawer MR, Ottman R, Hauser WA, Pedley TA. Autosomal dominant partial epilepsy with auditory features: defining the phenotype. Neurology. 2000;13(54):2173-6.
Michelucci R, Pulitano P, Di Bonaventura C, Binelli S, Luisi C, Pasini E, et al. The clinical phenotype of autosomal dominant lateral temporal lobe epilepsy related to reelin mutations. Epilepsy Behav. 2017;68:103-7.
Fanciulli M, Santulli L, Errichiello L, Barozzi C, Tomasi L, Rigon L, et al. LGI1 microdeletion in autosomal dominant lateral temporal epilepsy. Neurology. 2012;24(78):1299-303.
Dazzo E, Rehberg K, Michelucci R, Passarelli D, Boniver C, Vianello Dri V, et al. Mutations in MICAL-1 cause autosomal-dominant lateral temporal epilepsy. Ann Neurol. 2018;83:483-93.
Dazzo E, Fanciulli M, Serioli E, Minervini G, Pulitano P, Binelli S, et al. Heterozygous reelin mutations cause autosomal-dominant lateral temporal epilepsy. Am J Hum Genet. 2015;4(96):992-1000.
Pippucci T, Licchetta L, Baldassari S, Palombo F, Menghi V, D'Aurizio R, et al. Epilepsy with auditory features: a heterogeneous clinico-molecular disease. Neurol Genet. 2015;1:e5.
Hauser WA, Kurland LT. The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia. 1975;16:1-66.
Asadi-Pooya AA, Stewart GR, Abrams DJ, Sharan A. Prevalence and incidence of drug-resistant mesial temporal lobe epilepsy in the United States. World Neurosurg. 2017;99:662-6.
Cascino GD, Luckstein RR, Sharbrough FW, Jack CR Jr. Facial asymmetry, hippocampal pathology, and remote symptomatic seizures: a temporal lobe epileptic syndrome. Neurology. 1993;43:725-7.
Lewis DV, Shinnar S, Hesdorffer DC, Bagiella E, Bello JA, Chan S, et al. Hippocampal sclerosis after febrile status epilepticus: the FEBSTAT study. Ann Neurol. 2014;75:178-85.
Mathern GW, Pretorius JK, Babb TL. Influence of the type of initial precipitating injury and at what age it occurs on course and outcome in patients with temporal lobe seizures. J Neurosurg. 1995;82:220-7.
Davies KG, Hermann BP, Dohan FC Jr, Foley KT, Bush AJ, Wyler AR. Relationship of hippocampal sclerosis to duration and age of onset of epilepsy, and childhood febrile seizures in temporal lobectomy patients. Epilepsy Res. 1996;24:119-26.
Lewis DV. Febrile convulsions and mesial temporal sclerosis. Curr Opin Neurol. 1999;12:197-201.
Bleasel A, Kotagal P, Kankirawatana P, Rybicki L. Lateralizing value and semiology of ictal limb posturing and version in temporal lobe and extratemporal epilepsy. Epilepsia. 1997;38:168-74.
Dupont S, Samson Y, Nguyen-Michel V-H, Zavanone C, Navarro V, Baulac M, et al. Lateralizing value of semiology in medial temporal lobe epilepsy. Acta Neurol Scand. 2015;132:401-9.
Fakhoury T, Abou-Khalil B. Association of ipsilateral head turning and dystonia in temporal lobe seizures. Epilepsia. 1995;36(11):1065-70.
Gambardella A, Gotman J, Cendes F, Andermann F. Focal intermittent delta activity in patients with mesiotemporal atrophy: a reliable marker of the epileptogenic focus. Epilepsia. 1995;36(2):122-9.
Miley CE, Forster FM. Activation of partial complex seizures by hyperventilation. Arch Neurol. 1977;34:371-3.
Salanova V, Markand O, Worth R. Temporal lobe epilepsy: analysis of patients with dual pathology. Acta Neurol Scand. 2004;109:126-31.
Mehvari Habibabadi J, Badihian S, Tabrizi N, Manouchehri N, Zare M, Basiratnia R, et al. Evaluation of dual pathology among drug-resistant epileptic patients with hippocampal sclerosis. Neurol Sci. 2019;40:495-502.
Blümcke I, Thom M, Aronica E, Armstrong DD, Vinters HV, Palmini A, et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia. 2011;52:158-74.
Stevelink R, Sanders MWCB, Tuinman MP, Brilstra EH, Koeleman BPC, Jansen FE, et al. Epilepsy surgery for patients with genetic refractory epilepsy: a systematic review. Epileptic Disord. 2018;1(20):99-115.
Olson HE, Lechpammer M, Prabhu SP, Ciarlini PDSC, Poduri A, Gooty VD, et al. Clinical application and evaluation of the Bien diagnostic criteria for Rasmussen encephalitis. Epilepsia. 2013;54:1753-60.
Bien CG, Granata T, Antozzi C, Cross JH, Dulac O, Kurthen M, et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain. 2005;128:454-71.
Bien CG, Tiemeier H, Sassen R, Kuczaty S, Urbach H, von Lehe M, et al. Rasmussen encephalitis: incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins. Epilepsia. 2013;54:543-50.
Lamb K, Scott WJ, Mensah A, Robinson R, Varadkar S, Cross J. Prevalence and clinical outcome of Rasmussen encephalitis in children from the United Kingdom. Dev Med Child Neurol. 2013;55:14.
Varadkar S, Bien CG, Kruse CA, Jensen FE, Bauer J, Pardo CA, et al. Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances. Lancet Neurol. 2014;13:195-205.
Oguni H, Andermann F, Rasmussen TB. The syndrome of chronic encephalitis and epilepsy. A study based on the MNI series of 48 cases. Adv Neurol. 1992;57:419-33.
Dupont S, Gales A, Sammey S, Vidailhet M, Lambrecq V. Late-onset Rasmussen encephalitis: a literature appraisal. Autoimmun Rev. 2017;16:803-10.
Prayson RA. Dual pathology in Rasmussen’s encephalitis: a report of coexistent focal cortical dysplasia and review of the literature. Case Rep Pathol. 2012;2012:569170.
Chiapparini L, Granata T, Farina L, Ciceri E, Erbetta A, Ragona F, et al. Diagnostic imaging in 13 cases of Rasmussen's encephalitis: can early MRI suggest the diagnosis? Neuroradiology. 2003;45:171-83.
Radhakrishnan K, Silbert PL, Klass DW. Reading epilepsy. An appraisal of 20 patients diagnosed at the Mayo Clinic, Rochester, Minnesota, between 1949 and 1989, and delineation of the epileptic syndrome. Brain. 1995;118 (Pt 1):75-89.
Haykal MA, El-Feki A, Sonmezturk HH, Abou-Khalil BW. New observations in primary and secondary reading epilepsy: excellent response to levetiracetam and early spontaneous remission. Epilepsy Behav. 2012;23:466-70.
Miller S, Razvi S, Russell A. Reading epilepsy. Pract Neurol. 2010;10:278-81.
Valenti MP, Rudolf G, Carre S, Vrielynck P, Thibault A, Szepetowski P, et al. Language-induced epilepsy, acquired stuttering, and idiopathic generalized epilepsy: phenotypic study of one family. Epilepsia. 2006;47:766-72.
Wolf P. Reading epilepsy. In: Roger J, Bureau M, Dravet C, Dreifuss FE, Perret A, Wolf P, editors. Epileptic syndromes in infancy, childhood and adolescence. 2nd ed. London, UK: John Libbey; 1992. p. 281-98.
Millichap JG. Reading epilepsy response to anticonvulsants. Pediatr Neurol Briefs. 2012;26:39-40.
Striano P, Striano S. Reading epilepsy and its variants: a model for system epilepsy. Epilepsy Behav. 2011;20:591.
Ferlazzo E, Zifkin BG, Andermann E, Andermann F. Cortical triggers in generalized reflex seizures and epilepsies. Brain. 2005;128:700-10.
Koutroumanidis M, Koepp MJ, Richardson MP, Camfield C, Agathonikou A, Ried S, et al. The variants of reading epilepsy. A clinical and video-EEG study of 17 patients with reading-induced seizures. Brain. 1998;121(Pt 8):1409-27.
Genton P, Delgado-Escueta AV, Serratosa JM, Bureau M. Chapter 33: Progressive myoclonus epilepsies. In: Bureau M, Genton P, Dravet C, Delgado-Escueta AV, Tassinari CA, Thomas P, editors. Epileptic syndromes in infancy, childhood and adolescence. 5th ed. London, UK: John Libbey Eurotext; 2012. p. 575-606.
Magaudda A, Ferlazzo E, Nguyen VH, Genton P. Unverricht-Lundborg disease, a condition with self-limited progression: long-term follow-up of 20 patients. Epilepsia. 2006;47:860-6.
Norio R, Koskiniemi M. Progressive myoclonus epilepsy: genetic and nosological aspects with special reference to 107 Finnish patients. Clin Genet. 1979;15:382-98.
Hypponen J, Aikia M, Joensuu T, Julkunen P, Danner N, Koskenkorva P, et al. Refining the phenotype of Unverricht-Lundborg disease (EPM1): a population-wide Finnish study. Neurology. 2015;14(84):1529-36.
Ferlazzo E, Trenite D-N, Haan G-J, Felix Nitschke F, Ahonen S, Gasparini S, et al. Update on pharmacological treatment of progressive myoclonus epilepsies. Curr Pharm Des. 2017;23:5662-6.
Turnbull J, Tiberia E, Striano P, Genton P, Carpenter S, Ackerley CA, et al. Lafora disease. Epileptic Disord. 2016;1(18):38-62.
Ferlazzo E, Canafoglia L, Michelucci R, Gambardella A, Gennaro E, Pasini E, et al. Mild Lafora disease: clinical, neurophysiologic, and genetic findings. Epilepsia. 2014;55:e129-33.
Tassinari CA, Bureau-Paillas M, Dalla Bernardina B, Picornell-Darder I, Mouren MC, Dravet C, et al. La maladie de lafora. Rev Electroencephalogr Neurophysiol Clin. 1978;8(1):107-22.
Villanueva V, Alvarez-Linera J, Gómez-Garre P, Gutiérrez J, Serratosa JM. MRI volumetry and proton MR spectroscopy of the brain in Lafora disease. Epilepsia. 2006;47:788-92.
Muccioli L, Farolfi A, Pondrelli F, d’Orsi G, Michelucci R, Freri E, et al. FDG-PET assessment and metabolic patterns in Lafora disease. Eur J Nucl Med Mol Imaging. 2020;47:1576-84.
Serratosa JM, Delgado-Escueta AV, Posada I, Shih S, Drury I, Berciano J, et al. The gene for progressive myoclonus epilepsy of the Lafora type maps to chromosome 6q. Hum Mol Genet. 1995;4:1657-63.
Carpenter S, Karpati G. Sweat gland duct cells in Lafora disease: diagnosis by skin biopsy. Neurology. 1981;31:1564-8.
Nita DA, Mole SE, Minassian BA. Neuronal ceroid lipofuscinoses. Epileptic Disord. 2016;1(18):73-88.
Mole SE, Williams RE. Neuronal ceroid-lipofuscinoses - retired chapter, for historical reference only. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al. GeneReviews [Internet]. Seattle, WA: University of Washington; 2013. [cited 2022 Apr 9]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1428/
Moore SJ, Buckley DJ, MacMillan A, Marshall HD, Steele L, Ray PN, et al. The clinical and genetic epidemiology of neuronal ceroid lipofuscinosis in Newfoundland. Clin Genet. 2008;74:213-22.
Santorelli FM, Garavaglia B, Cardona F, Nardocci N, Bernardina BD, Sartori S, et al. Molecular epidemiology of childhood neuronal ceroid-lipofuscinosis in Italy. Orphanet J Rare Dis. 2013;2(8):19.
Specchio N, Bellusci M, Pietrafusa N, Trivisano M, de Palma L, Vigevano F. Photosensitivity is an early marker of neuronal ceroid lipofuscinosis type 2 disease. Epilepsia. 2017;58:1380-8.
Schulz A, Ajayi T, Specchio N, de Los Reyes E, Gissen P, Ballon D, et al. Study of intraventricular cerliponase alfa for CLN2 disease. N Engl J Med. 2018;17(378):1898-907.
Boustany RM. Neurology of the neuronal ceroid-lipofuscinoses: late infantile and juvenile types. Am J Med Genet. 1992;15(42):533-5.
Kitzmüller C, Haines RL, Codlin S, Cutler DF, Mole SE. A function retained by the common mutant CLN3 protein is responsible for the late onset of juvenile neuronal ceroid lipofuscinosis. Hum Mol Genet. 2008;15(17):303-12.
Berkovic SF, Carpenter S, Andermann F, Andermann E, Wolfe LS. Kufs’ disease: a critical reappraisal. Brain. 1988;111(Pt 1):27-62.
Arsov T, Smith K, Damiano J, Franceschetti S, Canafoglia L, Bromhead C, et al. Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, caused by mutations in CLN6. Am J Hum Genet. 2011;13(88):566-73.
Tatum WO, Hirsch LJ, Gelfand MA, Acton EK, LaFrance WC, Duckrow RB, et al. Assessment of the predictive value of outpatient smartphone videos for diagnosis of epileptic seizures. JAMA Neurol. 2020;1(77):593-600.
Steriade C, Britton J, Dale RC, Gadoth A, Irani SR, Linnoila J, et al. Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy: conceptual definitions. Epilepsia. 2020;61:1341-51.
Kotulska K, Kwiatkowski DJ, Curatolo P, Weschke B, Riney K, Jansen F, et al. Prevention of epilepsy in infants with tuberous sclerosis complex in the EPISTOP trial. Ann Neurol. 2021;89:304-14.